We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Committee Recommends Merck's Gardasil for Approval
FDA Committee Recommends Merck's Gardasil for Approval
May 26, 2006
The FDA’s Vaccines and Related Biological Products Advisory Committee has voted unanimously that data from clinical trials support the efficacy and safety of Gardasil, a biologic product Merck said is the first vaccine to prevent cervical cancer and other serious human papillomavirus (HPV)-related diseases.